Use of Cell-Free DNA Testing to Diagnose Infective Endocarditis in a Patient With Negative Blood Cultures

Robert Hennis1, Mark A Raynor1, Rivers A Hock1

  • 1Internal Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, USA.

Cureus
|October 24, 2024
PubMed

Insights

This study highlights a rare case of Streptococcus intermedius infective endocarditis. Cell-free DNA (cfDNA) testing successfully identified the pathogen and guided treatment, avoiding invasive procedures.

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Neurology

Background:

  • Infective endocarditis (IE) presents diagnostic challenges, impacting patient morbidity and mortality.
  • Identifying the causative pathogen is critical for effective IE management and treatment.
  • Rare presentations of IE require innovative diagnostic approaches.

Observation:

  • A rare case of Streptococcus intermedius infective endocarditis was observed.
  • The patient developed complications including lung and cerebral abscesses.
  • Standard diagnostic methods were challenging in this complex IE case.

Findings:

  • Cell-free deoxyribonucleic acid (cfDNA) testing was utilized to diagnose IE.
  • cfDNA testing successfully identified Streptococcus intermedius as the causative pathogen.
  • This diagnostic approach guided appropriate antibiotic therapy and patient management.

Implications:

  • Positive cfDNA test results obviated the need for invasive brain biopsy.
  • This case demonstrates the potential of cfDNA testing in complex IE diagnosis.
  • Findings suggest cfDNA testing may influence future diagnostic and therapeutic guidelines for IE.

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
2
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
2
Endocarditis II: Clinical features and Diagnostic Tests01:25

Endocarditis II: Clinical features and Diagnostic Tests

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
2
Myocarditis II: Clinical features and Diagnostic Tests01:27

Myocarditis II: Clinical features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
2